Product Images Wayrilz
View Photos of Packaging, Labels & Appearance
- Chemical Structure - 95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 01
- PRINCIPAL DISPLAY PANEL - 60 Tablet Carton - 95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 02
- PRINCIPAL DISPLAY PANEL - 28 Tablet Blister Pack - 95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 03
- PRINCIPAL DISPLAY PANEL - 56 Tablet Blister Pack Carton - 95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 04
Product Label Images
The following 4 images provide visual information about the product associated with Wayrilz NDC 58468-0251 by Genzyme Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 60 Tablet Carton - 95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 02

This is information about tablets called Wayrilz (rilzabrutinib) containing 60 tablets manufactured for sanofi. The recommended dosage and storage instructions are provided, including details on room temperature storage and protecting from light and moisture. A warning to keep out of children's reach is emphasized. Additionally, a website is provided for more information.*
PRINCIPAL DISPLAY PANEL - 28 Tablet Blister Pack - 95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 03

This description is not available.*
PRINCIPAL DISPLAY PANEL - 56 Tablet Blister Pack Carton - 95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 04

WAYRILZ A (rilzabrutinib) tablets are available in a dosage of 400 mg per tablet. Each packaging contains a total of 56 tablets, divided into two blister packs of 28 tablets each. It is a product from Sanofi, a reputable pharmaceutical company. The NDC for this product is 58468-0251-5.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.